EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Liver fibrosis-derived exosomal miR-106a-5p facilitates the malignancy by targeting SAMD12 and CADM2 in hepatocellular carcinoma

Juan Hu, Cong Xie, Shangcheng Xu, Qinli Pu, Han Liu, Liping Yang, Wei Wang, Longchun Mao, Zhiqiang Li, Weixian Chen iD

PLOS ONE · 25.05.2023 · 18 (5) · e0286017

DOI: 10.1371/journal.pone.0286017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 25.05.2023. Verfasst von Juan Hu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, MicroRNAs. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Incubation Fund Project (General Project) of The First Affiliated Hospital of Chongqing Medical and pharmaceutical College.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The mechanism of hepatocellular carcinoma (HCC) development induced by liver fibrosis is obscure. The objective of this study is to establish miRNAs from exosomes associated with liver fibrosis, and to identify potential biomarkers for the prediction of personalized clinical management effectiveness in HCC. Our research focused on miRNAs from exosomes and mRNA from liver fibrosis, which we found in the gene expression omnibus (GEO) database. Weighted gene co-expression network analysis (WGCNA) evaluated miRNAs from exosomes associated with liver fibrosis, and Wilcoxon analysis assessed differentially expressed mRNAs (DEGs) across liver fibrosis/normal tissues. Following that, DEGs were assessed through gene set enrichment analysis (GSEA), gene ontology (GO), and the Kyoto Encyclopedia of Genes and Genomes (KEGG). In addition, based on the screened targeted genes, including SAMD12 and CADM2, we further elucidated their correlation in HCC patients from the BEST database. The Kaplan-Meier Plotter platform was applied to evaluate the prognostic values of miRNA in HCC. In vitro and vivo experiments validated our findings. Six miRNAs associated with liver fibrosis were evaluated in our investigation. In-depth research presented exosome-derived miR-106a-5p, SAMD12 and CADM2 could exert valuable predictive implications for HCC treatment and illness assessment. Serum miR-106a-5p derived from liver fibrosis was decreased compared with healthy individuals. SAMD12 and CADM2 were diminished in liver cancer cell lines, and their knockdown of them exacerbated the proliferation capacities of liver cells in vitro. Exosome-derived miRNA of liver fibrosis modulated tumorigenesis by targeting SAMD12 and CADM2 in HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsMicroRNAsHumansCell Adhesion MoleculesGene Expression ProfilingGene Expression Regulation, NeoplasticLiver CirrhosisExosomesNerve Tissue Proteins

Substanzen

Cell Adhesion MoleculesMicroRNAsCADM2 protein, humanSAMD12 protein, humanNerve Tissue ProteinsMIRN106 microRNA, human

Autor:innen und Institutionen

  • Department of Laboratory Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • The First Affiliated Hospital of Chongqing Medical and Pharmaceutical College, Chongqing, China.
  • Department of Neurology, Jiulongpo District People's Hospital, Chongqing, China.

ORCID-Profile: Weixian Chen

Förderung

  • Research Incubation Fund Project (General Project) of The First Affiliated Hospital of Chongqing Medical and pharmaceutical College

Zitieren

APA

Hu, J., Xie, C., Xu, S., Pu, Q., Liu, H., Yang, L., Wang, W., Mao, L., Li, Z., & Chen, W. (2023). Liver fibrosis-derived exosomal miR-106a-5p facilitates the malignancy by targeting SAMD12 and CADM2 in hepatocellular carcinoma. PLOS ONE, 18(5), e0286017. https://doi.org/10.1371/journal.pone.0286017

Vancouver

Hu J, Xie C, Xu S, Pu Q, Liu H, Yang L, et al. Liver fibrosis-derived exosomal miR-106a-5p facilitates the malignancy by targeting SAMD12 and CADM2 in hepatocellular carcinoma. PLOS ONE. 2023;18(5):e0286017. doi:10.1371/journal.pone.0286017

BibTeX
@article{Hu2023,
  author = {Hu, Juan and Xie, Cong and Xu, Shangcheng and Pu, Qinli and Liu, Han and Yang, Liping and Wang, Wei and Mao, Longchun and Li, Zhiqiang and Chen, Weixian},
  title = {Liver fibrosis-derived exosomal miR-106a-5p facilitates the malignancy by targeting SAMD12 and CADM2 in hepatocellular carcinoma},
  journal = {PLOS ONE},
  year = {2023},
  volume = {18},
  number = {5},
  pages = {e0286017},
  doi = {10.1371/journal.pone.0286017}
}
Kostenlos starten →